Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
levosimendan (1 trial)
bay94-9392 (1 trial)
fludeoxyglucose f-18 (1 trial)
Cardiac Output, Low (Phase 3)
Multiple Pulmonary Nodules (Phase 2)
Trials (2 total)
Trial APIs (3 total)